Departure From Planned 39-Week Delivery for Fetal Congenital Heart Disease: Indications for Earlier Birth

Objective: Delivery >39 weeks’ gestation is recommended for fetuses with congenital heart disease (FCHD). However, hypertensive disorders of pregnancy (HDP), maternal diabetes and fetal growth restriction (FGR) are more common in these pregnancies and often necessitate early delivery. We evaluated indications for delivery at <39 weeks and examined maternal covariates, cardiac diagnoses and placental pathology. Study Design: This retrospective observational study included maternal-fetal dyads with prenatally diagnosed, structurally isolated, genetically unremarkable FCHD delivered at a single center. Gestational age and delivery indication were obtained from medical record. Placental pathology was assessed using Amsterdam criteria. Regression models evaluated associations with gestational age and neonatal mortality. Results: 46.3% (99/214) delivered <39 weeks; 65.6% (65/99) were due to maternal or fetal compromise, and 34.3% (33/99) to obstetric indications. HDP (20.1%) was strongly associated with <39-week delivery (32.3% vs 9.6%, p<0.001) and the greatest reduction in gestational age (−2.31 weeks, p<0.001). Multivariable analysis identified preeclampsia, type 2 diabetes, lower birthweight Z-score, and race as independent predictors of earlier delivery (p<0.05). Neonatal mortality was higher with maternal/fetal indications (15.7%) versus obstetric (5.4%) or elective FCHD delivery (5.6%) (p=0.02). Conclusion: Nearly half of FCHD infants delivered before 39 weeks, largely due to maternal and placental disease, underscoring the importance of placental health in this population.

Authors

Institutions

Publication Details

Journal
American Journal of Perinatology
Published
2026-11-19
DOI
https://doi.org/10.1055/a-3009-4548
Primary Topic
Congenital Heart Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Departure From Planned 39-Week Delivery for Fetal Congenital Heart Disease: Indications for Earlier Birth

Chrystalle Katte Carreon, Christina Ronai, Sarah U. Morton, Claire H. Packer et al.
American Journal of Perinatology
Congenital Heart Disease Studies
article

Departure From Planned 39-Week Delivery for Fetal Congenital Heart Disease: Indications for Earlier Birth

Chrystalle Katte Carreon, Christina Ronai, Sarah U. Morton, Claire H. Packer, Louise E. Wilkins-Haug, Stephanie H. Guseh
article en

Abstract

Objective: Delivery >39 weeks’ gestation is recommended for fetuses with congenital heart disease (FCHD). However, hypertensive disorders of pregnancy (HDP), maternal diabetes and fetal growth restriction (FGR) are more common in these pregnancies and often necessitate early delivery. We evaluated indications for delivery at <39 weeks and examined maternal covariates, cardiac diagnoses and placental pathology. Study Design: This retrospective observational study included maternal-fetal dyads with prenatally diagnosed, structurally isolated, genetically unremarkable FCHD delivered at a single center. Gestational age and delivery indication were obtained from medical record. Placental pathology was assessed using Amsterdam criteria. Regression models evaluated associations with gestational age and neonatal mortality. Results: 46.3% (99/214) delivered <39 weeks; 65.6% (65/99) were due to maternal or fetal compromise, and 34.3% (33/99) to obstetric indications. HDP (20.1%) was strongly associated with <39-week delivery (32.3% vs 9.6%, p<0.001) and the greatest reduction in gestational age (−2.31 weeks, p<0.001). Multivariable analysis identified preeclampsia, type 2 diabetes, lower birthweight Z-score, and race as independent predictors of earlier delivery (p<0.05). Neonatal mortality was higher with maternal/fetal indications (15.7%) versus obstetric (5.4%) or elective FCHD delivery (5.6%) (p=0.02). Conclusion: Nearly half of FCHD infants delivered before 39 weeks, largely due to maternal and placental disease, underscoring the importance of placental health in this population.

American Journal of Perinatology
Brigham and Women's Hospital (US), Boston Children's Hospital (US), Harvard University (US), University of California, San Francisco (US)
Congenital Heart Disease Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon